Capital Counsel LLC NY Cuts Stock Holdings in Mettler-Toledo International, Inc. $MTD

Capital Counsel LLC NY lessened its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 1.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 148,199 shares of the medical instruments supplier’s stock after selling 2,760 shares during the period. Mettler-Toledo International accounts for about 7.1% of Capital Counsel LLC NY’s portfolio, making the stock its 9th largest position. Capital Counsel LLC NY owned 0.72% of Mettler-Toledo International worth $174,092,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of Mettler-Toledo International by 0.5% in the 2nd quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier’s stock worth $3,003,415,000 after buying an additional 13,342 shares during the period. Bank of New York Mellon Corp raised its holdings in shares of Mettler-Toledo International by 71.3% in the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock valued at $1,062,257,000 after acquiring an additional 376,419 shares in the last quarter. Alliancebernstein L.P. lifted its stake in Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after acquiring an additional 126,147 shares during the period. Geode Capital Management LLC grew its holdings in Mettler-Toledo International by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock worth $681,489,000 after acquiring an additional 3,383 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its holdings in Mettler-Toledo International by 5.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock worth $568,032,000 after acquiring an additional 25,272 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

MTD has been the topic of a number of recent research reports. Wells Fargo & Company raised their price objective on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, November 10th. Citigroup lifted their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Robert W. Baird increased their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research report on Monday, August 4th. Stifel Nicolaus raised their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Finally, Evercore ISI lifted their price target on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Five investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $1,406.50.

Insider Activity

In other news, Director Elisha W. Finney sold 474 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total transaction of $679,512.18. Following the sale, the director owned 311 shares of the company’s stock, valued at $445,840.27. This trade represents a 60.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Patrick Kaltenbach sold 2,000 shares of the business’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $1,462.50, for a total transaction of $2,925,000.00. Following the completion of the transaction, the chief executive officer owned 3,670 shares of the company’s stock, valued at approximately $5,367,375. This represents a 35.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 19,565 shares of company stock valued at $28,683,737 over the last 90 days. Company insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock opened at $1,476.72 on Monday. The stock has a market cap of $30.17 billion, a PE ratio of 37.39, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41. The firm has a fifty day moving average price of $1,368.76 and a 200 day moving average price of $1,274.95. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating the consensus estimate of $10.62 by $0.53. The company had revenue of $1.03 billion for the quarter, compared to analyst estimates of $997.36 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm’s revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the company earned $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.